Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


August 31, 2015 9:17 AM ET

Pharmaceuticals

Company Overview of Shire plc

Executive Profile

Mark J. Enyedy

Head of Corporate Development, Shire plc
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 5 different industries.

See Board Relationships
51--

Background

Mr. Mark J. Enyedy has been Head of Corporate Development at Shire plc since January 1, 2015. Mr. Enyedy joined Shire in 2013 and served as its Internal Medicine Business Unit Head from August 2013 to April 2014. Mr. Enyedy served as the Interim General Counsel of Shire plc from January 1, 2015 to June 15, 2015. He served as the Chief Executive Officer of Proteostasis Therapeutics, Inc. Mr. Enyedy joined Proteostasis after serving 15 years at Genzyme Corporation. He ...

Corporate Headquarters

5 Riverwalk
Dublin, Co. Dublin 24

Ireland

Phone: 353 1 429 7700
Fax: --

Board Members Memberships

2012-Present
Director, Chairman of Compensation Committee and Member of Audit Committee

Education

Bachelor's Degree
Northeastern University
JD
Harvard Law School

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Heather Bresch Chief Executive Officer, Executive Director and Member of Science & Technology Committee
Mylan N.V.
$1.2M
Joseph C. Papa Chairman, Chief Executive Officer and President
Perrigo Company Public Limited Company
$1.1M
Haruo Naito Chief Executive Officer, Representative Corporate Officer and Director
Eisai Co., Ltd.
$119.0M
Paul R. Perreault BA PsychologyChief Executive Officer, Managing Director, Executive Director, Member of Innovation & Development Committee and Member of Securities & Market Disclosure Committee
CSL Ltd.
$2.9M
F. Michael Ball Chief Executive Officer, Director and Member of Science & Technology Committee
Hospira Inc.
$1.1M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Shire plc, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.